Medicine recalls
|
| |
| The United States: Vital Rx, Inc. d/b/a Atlantic Pharmacy and Compounding issues voluntary nationwide recall of all compounded injectable prescription medications due to lack of sterility assurance |
| |
The US Food and Drug Administration (FDA) announces that Vital Rx, Inc. d/b/a Atlantic Pharmacy and Compounding is voluntarily recalling all lots of all compounded injectable prescription medications to the consumer level. The compounded injectable prescription medications have been found to lack sterility assurance. Atlantic Pharmacy and Compounding became aware of this issue during an FDA inspection of the pharmacy. The compounded injectable prescription is packaged in sterile vials for injection. The compounded injectable prescription medications potentially could result in adverse effects. To date, Vital Rx, Inc. d/b/a Atlantic Pharmacy and Compounding has not received any reports of adverse events related to this recall.
Please refer to the following website in FDA for details:
http://www.fda.gov/Safety/Recalls/ucm572262.htm
In Hong Kong, there is no registered pharmaceutical product manufactured by the above company. Related news was previously issued by FDA, and was posted on the Drug Office website on 11 Aug 2017.
Ends/Monday, Aug 21, 2017
Issued at HKT 12:00
|
| |
|
